AUDRA BIRZER: Open Payments
NPI 1316572076 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,378 in 62 payments from 31 companies in 2025. Trend: 2023 $506 · 2024 $884 · 2025 $1,378
Food & beverage: $1,378
| Company | Payments | Amount |
|---|---|---|
| Stemline Therapeutics Inc. | 5 | $193 |
| AstraZeneca Pharmaceuticals LP | 10 | $174 |
| Novocure Inc. | 4 | $144 |
| Novartis Pharmaceuticals Corporation | 5 | $102 |
| Genentech USA, Inc. | 3 | $55 |
| TerSera Therapeutics LLC | 2 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
Products named: Orserdu, Optune Lua (NovoTTF-200T), ENHERTU, KEYTRUDA, KISQALI, LUTATHERA, ORGOVYX, Doptelet.
Industry payments across KS — which companies pay providers there.
